Loading…

Stability of Cardiac Troponin-I in Whole Blood and Plasma in Patients with Acute Myocardial Infarction

Introduction: In this study, we aimed to investigate the short-term stability and variability of cardiac troponin T (cTnI) in ethylenediamine tetraacetic acid (EDTA) whole blood, heparinized whole blood, and EDTA plasma. Methods: Thirteen patients with myocardial infarction were included. Venous blo...

Full description

Saved in:
Bibliographic Details
Published in:Istanbul medical journal 2021-02, Vol.22 (1), p.68-72
Main Authors: Karabulut, Umut, Karabulut, Dilay, Kasapoğlu, Pınar, Yazan, Serkan, Ertürk, Mehmet, Koşer, Murat, Işıksaçan, Nilgün
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 72
container_issue 1
container_start_page 68
container_title Istanbul medical journal
container_volume 22
creator Karabulut, Umut
Karabulut, Dilay
Kasapoğlu, Pınar
Yazan, Serkan
Ertürk, Mehmet
Koşer, Murat
Işıksaçan, Nilgün
description Introduction: In this study, we aimed to investigate the short-term stability and variability of cardiac troponin T (cTnI) in ethylenediamine tetraacetic acid (EDTA) whole blood, heparinized whole blood, and EDTA plasma. Methods: Thirteen patients with myocardial infarction were included. Venous blood samples (24 mL) from all patients were collected into vacuum tubes with EDTA and heparin (Becton Dickinson-USA), and analyses were performed on four different groups (one group for repeatability and three groups for stability). Results: There was no statistically significant difference in cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours between the heparinized whole blood, EDTA whole blood, and EDTA plasma groups (group 2) (p>0.05). In the heparinized whole blood and EDTA plasma groups, there was a statistically significant difference between cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours. In the EDTA whole blood group, there was no statistically significant difference between any time points. Conclusion: The interclass and intraclass correlation coefficients of the EDTA whole blood group were sufficiently high, which indicates better stability. EDTA whole blood samples are preferable for cTnI measurement because they are stable for 48 hours. EDTA-containing tubes are easy to find in clinical laboratories and do not need to be centrifuged, which saves time and effort.
doi_str_mv 10.4274/imj.galenos.2021.66049
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_proquest_journals_2833206161</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_fd4bcd0afe154b8cb621d8671e0c0199</doaj_id><sourcerecordid>2833206161</sourcerecordid><originalsourceid>FETCH-LOGICAL-c226t-bb9fdcf449a5b0f6d886738a71f6a564992ad3300d3ecedc1a63a721224bf6dc3</originalsourceid><addsrcrecordid>eNo9kdtKAzEQhhdRUNRXkIDXW3Pa7OZSi4dCRUFF78JsDpqyTWqSIn17t614NcPMzzcDX1VdEDzhtOVXfrmYfMJgQ8wTiimZCIG5PKhOKOFdjSX_OBx7QWQtW8mOq_OcFxhj2jWia-hJ5V4K9H7wZYOiQ1NIxoNGrymuYvChniEf0PtXHCy6GWI0CIJBzwPkJWw3z1C8DSWjH1--0LVeF4seN1HvMAOaBQdJFx_DWXXkYMj2_K-eVm93t6_Th3r-dD-bXs9rTakodd9LZ7TjXELTYydM14mWddASJ6ARXEoKhjGMDbPaGk1AMGgpoZT3Y1qz02q255oIC7VKfglpoyJ4tRvE9KkgFa8Hq5zhvTYYnCUN7zvdC0rMeI5YrDGRcmRd7lmrFL_XNhe1iOsUxvcV7RijWBBBxpTYp3SKOSfr_q8SrLaK1KhI_SlSW0Vqp4j9AmN1iBM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2833206161</pqid></control><display><type>article</type><title>Stability of Cardiac Troponin-I in Whole Blood and Plasma in Patients with Acute Myocardial Infarction</title><source>Publicly Available Content Database</source><creator>Karabulut, Umut ; Karabulut, Dilay ; Kasapoğlu, Pınar ; Yazan, Serkan ; Ertürk, Mehmet ; Koşer, Murat ; Işıksaçan, Nilgün</creator><creatorcontrib>Karabulut, Umut ; Karabulut, Dilay ; Kasapoğlu, Pınar ; Yazan, Serkan ; Ertürk, Mehmet ; Koşer, Murat ; Işıksaçan, Nilgün</creatorcontrib><description>Introduction: In this study, we aimed to investigate the short-term stability and variability of cardiac troponin T (cTnI) in ethylenediamine tetraacetic acid (EDTA) whole blood, heparinized whole blood, and EDTA plasma. Methods: Thirteen patients with myocardial infarction were included. Venous blood samples (24 mL) from all patients were collected into vacuum tubes with EDTA and heparin (Becton Dickinson-USA), and analyses were performed on four different groups (one group for repeatability and three groups for stability). Results: There was no statistically significant difference in cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours between the heparinized whole blood, EDTA whole blood, and EDTA plasma groups (group 2) (p&gt;0.05). In the heparinized whole blood and EDTA plasma groups, there was a statistically significant difference between cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours. In the EDTA whole blood group, there was no statistically significant difference between any time points. Conclusion: The interclass and intraclass correlation coefficients of the EDTA whole blood group were sufficiently high, which indicates better stability. EDTA whole blood samples are preferable for cTnI measurement because they are stable for 48 hours. EDTA-containing tubes are easy to find in clinical laboratories and do not need to be centrifuged, which saves time and effort.</description><identifier>ISSN: 2619-9793</identifier><identifier>ISSN: 1304-8503</identifier><identifier>EISSN: 2148-094X</identifier><identifier>DOI: 10.4274/imj.galenos.2021.66049</identifier><language>eng</language><publisher>Istanbul: Galenos Publishing House</publisher><subject>acute myocardial infarction ; Antibodies ; Anticoagulants ; Blood groups ; cardiac troponin-i ; Emergency medical care ; Heart attacks ; Plasma ; whole blood</subject><ispartof>Istanbul medical journal, 2021-02, Vol.22 (1), p.68-72</ispartof><rights>2021. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-2468-2793 ; 0000-0002-0230-6500 ; 0000-0003-1896-0096 ; 0000-0001-7102-0875 ; 0000-0002-3947-9173 ; 0000-0003-1703-2204 ; 0000-0003-4456-6818</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2833206161/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2833206161?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,25732,27903,27904,36991,44569,74872</link.rule.ids></links><search><creatorcontrib>Karabulut, Umut</creatorcontrib><creatorcontrib>Karabulut, Dilay</creatorcontrib><creatorcontrib>Kasapoğlu, Pınar</creatorcontrib><creatorcontrib>Yazan, Serkan</creatorcontrib><creatorcontrib>Ertürk, Mehmet</creatorcontrib><creatorcontrib>Koşer, Murat</creatorcontrib><creatorcontrib>Işıksaçan, Nilgün</creatorcontrib><title>Stability of Cardiac Troponin-I in Whole Blood and Plasma in Patients with Acute Myocardial Infarction</title><title>Istanbul medical journal</title><description>Introduction: In this study, we aimed to investigate the short-term stability and variability of cardiac troponin T (cTnI) in ethylenediamine tetraacetic acid (EDTA) whole blood, heparinized whole blood, and EDTA plasma. Methods: Thirteen patients with myocardial infarction were included. Venous blood samples (24 mL) from all patients were collected into vacuum tubes with EDTA and heparin (Becton Dickinson-USA), and analyses were performed on four different groups (one group for repeatability and three groups for stability). Results: There was no statistically significant difference in cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours between the heparinized whole blood, EDTA whole blood, and EDTA plasma groups (group 2) (p&gt;0.05). In the heparinized whole blood and EDTA plasma groups, there was a statistically significant difference between cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours. In the EDTA whole blood group, there was no statistically significant difference between any time points. Conclusion: The interclass and intraclass correlation coefficients of the EDTA whole blood group were sufficiently high, which indicates better stability. EDTA whole blood samples are preferable for cTnI measurement because they are stable for 48 hours. EDTA-containing tubes are easy to find in clinical laboratories and do not need to be centrifuged, which saves time and effort.</description><subject>acute myocardial infarction</subject><subject>Antibodies</subject><subject>Anticoagulants</subject><subject>Blood groups</subject><subject>cardiac troponin-i</subject><subject>Emergency medical care</subject><subject>Heart attacks</subject><subject>Plasma</subject><subject>whole blood</subject><issn>2619-9793</issn><issn>1304-8503</issn><issn>2148-094X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNo9kdtKAzEQhhdRUNRXkIDXW3Pa7OZSi4dCRUFF78JsDpqyTWqSIn17t614NcPMzzcDX1VdEDzhtOVXfrmYfMJgQ8wTiimZCIG5PKhOKOFdjSX_OBx7QWQtW8mOq_OcFxhj2jWia-hJ5V4K9H7wZYOiQ1NIxoNGrymuYvChniEf0PtXHCy6GWI0CIJBzwPkJWw3z1C8DSWjH1--0LVeF4seN1HvMAOaBQdJFx_DWXXkYMj2_K-eVm93t6_Th3r-dD-bXs9rTakodd9LZ7TjXELTYydM14mWddASJ6ARXEoKhjGMDbPaGk1AMGgpoZT3Y1qz02q255oIC7VKfglpoyJ4tRvE9KkgFa8Hq5zhvTYYnCUN7zvdC0rMeI5YrDGRcmRd7lmrFL_XNhe1iOsUxvcV7RijWBBBxpTYp3SKOSfr_q8SrLaK1KhI_SlSW0Vqp4j9AmN1iBM</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Karabulut, Umut</creator><creator>Karabulut, Dilay</creator><creator>Kasapoğlu, Pınar</creator><creator>Yazan, Serkan</creator><creator>Ertürk, Mehmet</creator><creator>Koşer, Murat</creator><creator>Işıksaçan, Nilgün</creator><general>Galenos Publishing House</general><general>Galenos Yayinevi</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2468-2793</orcidid><orcidid>https://orcid.org/0000-0002-0230-6500</orcidid><orcidid>https://orcid.org/0000-0003-1896-0096</orcidid><orcidid>https://orcid.org/0000-0001-7102-0875</orcidid><orcidid>https://orcid.org/0000-0002-3947-9173</orcidid><orcidid>https://orcid.org/0000-0003-1703-2204</orcidid><orcidid>https://orcid.org/0000-0003-4456-6818</orcidid></search><sort><creationdate>20210201</creationdate><title>Stability of Cardiac Troponin-I in Whole Blood and Plasma in Patients with Acute Myocardial Infarction</title><author>Karabulut, Umut ; Karabulut, Dilay ; Kasapoğlu, Pınar ; Yazan, Serkan ; Ertürk, Mehmet ; Koşer, Murat ; Işıksaçan, Nilgün</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c226t-bb9fdcf449a5b0f6d886738a71f6a564992ad3300d3ecedc1a63a721224bf6dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>acute myocardial infarction</topic><topic>Antibodies</topic><topic>Anticoagulants</topic><topic>Blood groups</topic><topic>cardiac troponin-i</topic><topic>Emergency medical care</topic><topic>Heart attacks</topic><topic>Plasma</topic><topic>whole blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karabulut, Umut</creatorcontrib><creatorcontrib>Karabulut, Dilay</creatorcontrib><creatorcontrib>Kasapoğlu, Pınar</creatorcontrib><creatorcontrib>Yazan, Serkan</creatorcontrib><creatorcontrib>Ertürk, Mehmet</creatorcontrib><creatorcontrib>Koşer, Murat</creatorcontrib><creatorcontrib>Işıksaçan, Nilgün</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Istanbul medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karabulut, Umut</au><au>Karabulut, Dilay</au><au>Kasapoğlu, Pınar</au><au>Yazan, Serkan</au><au>Ertürk, Mehmet</au><au>Koşer, Murat</au><au>Işıksaçan, Nilgün</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stability of Cardiac Troponin-I in Whole Blood and Plasma in Patients with Acute Myocardial Infarction</atitle><jtitle>Istanbul medical journal</jtitle><date>2021-02-01</date><risdate>2021</risdate><volume>22</volume><issue>1</issue><spage>68</spage><epage>72</epage><pages>68-72</pages><issn>2619-9793</issn><issn>1304-8503</issn><eissn>2148-094X</eissn><abstract>Introduction: In this study, we aimed to investigate the short-term stability and variability of cardiac troponin T (cTnI) in ethylenediamine tetraacetic acid (EDTA) whole blood, heparinized whole blood, and EDTA plasma. Methods: Thirteen patients with myocardial infarction were included. Venous blood samples (24 mL) from all patients were collected into vacuum tubes with EDTA and heparin (Becton Dickinson-USA), and analyses were performed on four different groups (one group for repeatability and three groups for stability). Results: There was no statistically significant difference in cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours between the heparinized whole blood, EDTA whole blood, and EDTA plasma groups (group 2) (p&gt;0.05). In the heparinized whole blood and EDTA plasma groups, there was a statistically significant difference between cTnI concentrations at baseline, 2, 4, 6, 12, 24, and 48 hours. In the EDTA whole blood group, there was no statistically significant difference between any time points. Conclusion: The interclass and intraclass correlation coefficients of the EDTA whole blood group were sufficiently high, which indicates better stability. EDTA whole blood samples are preferable for cTnI measurement because they are stable for 48 hours. EDTA-containing tubes are easy to find in clinical laboratories and do not need to be centrifuged, which saves time and effort.</abstract><cop>Istanbul</cop><pub>Galenos Publishing House</pub><doi>10.4274/imj.galenos.2021.66049</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-2468-2793</orcidid><orcidid>https://orcid.org/0000-0002-0230-6500</orcidid><orcidid>https://orcid.org/0000-0003-1896-0096</orcidid><orcidid>https://orcid.org/0000-0001-7102-0875</orcidid><orcidid>https://orcid.org/0000-0002-3947-9173</orcidid><orcidid>https://orcid.org/0000-0003-1703-2204</orcidid><orcidid>https://orcid.org/0000-0003-4456-6818</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2619-9793
ispartof Istanbul medical journal, 2021-02, Vol.22 (1), p.68-72
issn 2619-9793
1304-8503
2148-094X
language eng
recordid cdi_proquest_journals_2833206161
source Publicly Available Content Database
subjects acute myocardial infarction
Antibodies
Anticoagulants
Blood groups
cardiac troponin-i
Emergency medical care
Heart attacks
Plasma
whole blood
title Stability of Cardiac Troponin-I in Whole Blood and Plasma in Patients with Acute Myocardial Infarction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T23%3A27%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stability%20of%20Cardiac%20Troponin-I%20in%20Whole%20Blood%20and%20Plasma%20in%20Patients%20with%20Acute%20Myocardial%20Infarction&rft.jtitle=Istanbul%20medical%20journal&rft.au=Karabulut,%20Umut&rft.date=2021-02-01&rft.volume=22&rft.issue=1&rft.spage=68&rft.epage=72&rft.pages=68-72&rft.issn=2619-9793&rft.eissn=2148-094X&rft_id=info:doi/10.4274/imj.galenos.2021.66049&rft_dat=%3Cproquest_doaj_%3E2833206161%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c226t-bb9fdcf449a5b0f6d886738a71f6a564992ad3300d3ecedc1a63a721224bf6dc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2833206161&rft_id=info:pmid/&rfr_iscdi=true